Editor’s Note The story of botanical drugs is one of persistence — and promise. In nearly twenty years, the FDA has approved only four botanical or plant-based products, yet more than 700 INDs and pre-IND requests tell a different story: momentum is building. Advances in analytics, rising patient demand for natural therapies, and new global [...]